Cite
HARVARD Citation
Ganju, J. et al. (2015). Response to 'Inclusion of Placebos and Blinding for Ascending Dose First‐in‐Human Studies and Other Underpowered Phase 1 studies has not been Justified and on Balance is Not Useful' by D.A. Parasrampuria and L.Z. Benet. Basic & clinical pharmacology & toxicology. 117 (6), pp. 365-366. [Online].